Overview

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

Status:
RECRUITING
Trial end date:
2030-06-27
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the long-term safety and tolerability after an intravitreal injection (a shot of medicine into the eye) of JNJ-81201887 administered in parent clinical studies.
Phase:
PHASE2
Details
Lead Sponsor:
Janssen Research & Development, LLC